Indomethacin overcomes doxorubicin resistance by decreasing intracellular content of glutathione and its conjugates with decreasing expression of gamma-glutamylcysteine synthetase via promoter activity in doxorubicin-resistant leukemia cells.

Source:http://linkedlifedata.com/resource/pubmed/id/19153736

Download in:

View as

General Info

PMID
19153736